Biotechnology: Human Health
Download
1 / 28

Biotechnology: Human Health - PowerPoint PPT Presentation


  • 101 Views
  • Uploaded on

Biotechnology: Human Health. Prof. B. D Lakhchaura. State Biotechnology Programme, Govt. of Uttaranchal Biotech Bahavan, Haldi, U.S. Nagar . Recombinant DNA Technology ushered a revolution in Biotechnology. US Biotech Company “Genetech” cloned Human Insulin gene in E-coli 1978 .

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'Biotechnology: Human Health' - ivory


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

Biotechnology: Human Health

Prof. B. D Lakhchaura

State Biotechnology Programme, Govt. of Uttaranchal Biotech Bahavan, Haldi, U.S. Nagar


Recombinant DNA Technology ushered a revolution in Biotechnology

  • US Biotech Company “Genetech” cloned Human Insulin gene in E-coli 1978


Molecular Biotechnology can be exploited for application in Medical Science for the following:

1. Development of rapid and accurate diagnostic methods against infectious and non-infectious ailments.

2. Development of prophylactics and therapeutics for prevention and treatment of the disease


Production of various Recombinant Proteins by Prokaryotic and Eukaryotic cells

Recombinant proteins produced by S. cerevisiae expression system


Recombinant Baculo viruses have been used with insect cell lines for producing high yield of recombinant proteins which can be used as diagnostics, prophylactics & therapeutics


Similarly number of mammalian cell lines have been used for producing proteins consisting of multi peptides


Production of molecular diagnostics producing proteins consisting of multi peptides

ELISA a simple but highly sensitive immuno diagnostic assay system


Discovery of Hybridoma technology for producing monoclonal antibody added the much needed specificity dimension to immuno-diagnostic procedures



Use of nucleic acid hybridization probes as diagnostic agents

  • Initially radioactive probes were used which required viewing after autoradiography

  • Now a days non-radioactive probes have been develop for diagnosis of various diseases such as:

  • Malaria

  • Legionella pneumopholia

  • Salmonella typhi

  • Campilobacter hyointstinalis

  • Escherichia coli

  • Trypnosoma ruzi (chagas desies uses PCR for detection for 188 bp DNA)





As all genetic changes not necessarily altered restriction sites PCR/ OLA procedure can be used for detecting genetic changes


Using c-DNA cloning a large number of human proteins have been produced a partial list is given below


Use of Murine monoclonal antibodies as therapeutic agents been produced a partial list is given below


A novel way to dissolve arterial blood clots been produced a partial list is given below


OKT-3 a murine monoclonal antibody cleared by FDA for use as immuno suppressive agent for patients receiving organ transplant

Humanization of the Meurin monoclonal antibodies makes them useful for treatment in Humans. These therapy are specially valuable for treatment of Cancer


Views of immuno suppressive agent for patients receiving organ transplantPseudomous exotoxin A conjugate with CD 4 coding sequence creates a potential drug for treatment of HIV


Genetic construction of immuno suppressive agent for patients receiving organ transplantPseudomous exotoxin -a conjugate with CD-4 vector


Live attenuated vaccine against immuno suppressive agent for patients receiving organ transplantVibrio cholerae


Human Gene Therapy immuno suppressive agent for patients receiving organ transplant

Number of single gene disorders have been selected for gene therapy


Use of vector for gene therapy: a typical illustration immuno suppressive agent for patients receiving organ transplant


Two forms of Human Gene Therapy immuno suppressive agent for patients receiving organ transplant

1. Ex-vivo Gene Therapy

2. In-vivo Gene Therapy


Most exciting area of Biotechnology research being perused currently

  • Major Sources of stem cells

  • Undifferentiated embryos or single cells from the embryos

  • 2. Chord Blood

  • 3. Bone marrow


Applications of Stem Cells currently

  • Organ transplant – renewal of organs such as degenerative liver, heart, lungs or blood cells using stem cells

  • For creating transgenic animal lines for studying human disorders like Cystic fibrosis, Alzheimer's, Parkinson’s diseases etc.

  • For treatment of brain disorders such as Parkinson’s diseases, Alzheimer's disease or multiple sclerosis or other diseases of brain and spinal cord


Conclusions currently

Global scenario of Biotechnological application in human health in enjoys enormous excitement and worthwhile achievements in areas of

  • Prophylactic – Vaccines (attenuated whole cell vaccines, peptide vaccines, DNA vaccines)

  • Diagnostics – molecular diagnostics using immunological techniques and nucleic acid based techniques

  • Therapeutic agent development – drug designing, drug targeting, gene therapy are becoming applicable in the field

As far as India is concerned the research in medical biotechnology remains and limited to certain areas such as development of subunit vaccines, DNA vaccines and diagnostic kits for detection of viral diseases like HIV etc. Medical biotechnology requires a greater focus and more strengthening public and private sources. More investment in R & D can only fetch results which can have global significance.


Thanks currently


ad